Patents Assigned to IMMUNIS.AI, INC.
  • Patent number: 11585814
    Abstract: The invention described herein provides biological markers for the diagnosis, prognosis, and monitoring of prostate cancer.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: February 21, 2023
    Assignee: IMMUNIS.AI, INC.
    Inventors: Amin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wojno